Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,227,820,098
-
Total 13F shares
-
237,677,230
-
Share change
-
-11,189,399
-
Total reported value
-
$11,218,512,587
-
Put/Call ratio
-
96%
-
Price per share
-
$47.20
-
Number of holders
-
701
-
Value change
-
-$539,879,761
-
Number of buys
-
316
-
Number of sells
-
342
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q3 2025
As of 30 Sep 2025,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
701 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
237,677,230 shares.
The largest 10 holders included
Dodge & Cox, Fisher Asset Management, LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, BARROW HANLEY MEWHINNEY & STRAUSS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, and FRANKLIN RESOURCES INC.
This page lists
701
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.